Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

IRSA Posts ARS 6,380M Q1 FY2027 Net Loss

IRSA Inversiones y Representaciones S.A. filed its first-quarter fiscal year 2027 results via press release on November 4, 2026, covering the three-month period ended September 30, 2026.

Aditi Sarkar | 04 November 2026

Silicom Wins Cyber Security Expansion, Eyes $10M in 2027

Silicom Ltd. filed an 8-K press release on November 4, 2026, announcing an expanded relationship with an existing cyber security customer, with total business from that customer expected to exceed $10 million in 2027.

Shwetambri Chauhan | 04 November 2026

Carnival Corporation Launches $2.0 Billion Commercial Paper Program

Carnival Corporation Ltd. filed a current report on November 4, 2026, disclosing that on November 3, 2026, the company established a commercial paper program allowing it to issue up to $2.0 billion in short-term, unsecured notes.

Shwetambri Chauhan | 04 November 2026

SmartRent Files Q3 2026 Report With 189.8M Shares Out

SmartRent, Inc. filed its quarterly report on Form 10-Q with the U.S. Securities and Exchange Commission on November 4, 2026, covering the fiscal quarter ended September 30, 2026.

Aditi Sarkar | 04 November 2026

Safehold Q3 2026: Revenue Rises to $344.2M Nine-Month Total

Safehold Inc. filed its quarterly report on Form 10-Q with the SEC on November 4, 2026, covering the fiscal quarter ended September 30, 2026, disclosing consolidated financial results and balance sheet data for the period.

Aakashdeep | 04 November 2026

Jasper Therapeutics Executes 1-for-30 Reverse Stock Split

Jasper Therapeutics, Inc. filed a Form 8-K on November 4, 2026, disclosing that it effected a 1-for-30 reverse stock split of its voting common stock, with the split becoming effective at 12:01 a.m. Eastern Time on November 6, 2026.

Shwetambri Chauhan | 04 November 2026

Processa Pharma Names Gregory Flesher as COO

Processa Pharmaceuticals, Inc. filed a Form 8-K on November 4, 2026, disclosing the appointment of Gregory J. Flesher as Chief Operating Officer, effective November 4, 2026, along with the terms of his compensation arrangement.

Nitish Kishor | 04 November 2026

Nuvectis Pharma Q3 2026: 34.4M Shares Outstanding

Nuvectis Pharma, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026 with the U.S. Securities and Exchange Commission on November 4, 2026, disclosing financial results and operational details for the three and nine months ended September 30, 2026.

Aakashdeep | 04 November 2026

Thomas Spruce Exits, Peter Hager Takes Multiple Roles at XESP

Electronic Servitor Publication Network, Inc. filed a Form 8-K on November 4, 2026, disclosing the resignation of Thomas Spruce and the appointment of Peter Hager to multiple interim officer and director positions.

Vinay Lochav | 04 November 2026

Al-Amudi and Townes-Whitley Join JLL Board December 1

Jones Lang LaSalle Incorporated filed a Form 8-K on November 4, 2026, disclosing that its Board of Directors elected Nabeel Al-Amudi and Toni Townes-Whitley as independent, non-executive directors, effective December 1, 2026.

Manish Choudhary | 04 November 2026
Support

Hi! How can we help you today?

Loading…